Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Polyoxyethylene-660-12-hydroxy stearate (solutol-HS15) containing radix bupleuri injection drug preparation and preparation method thereof

A technology of polyethylene glycol lauryl hydroxystearate and injection preparations, which is applied in the field of Bupleurum drug injection preparations and its preparation, which can solve the problems of increased impurity content, turbid solution, and prone to precipitation solution, etc., and achieve high solubilization ability , improve safety, and avoid adverse reactions

Inactive Publication Date: 2014-10-29
CHENGDU LIST PHARMA
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, Bupleurum Injection is prone to problems such as precipitation and solution turbidity during high temperature sterilization and long-term storage.
Current Bupleurum injections all use polysorbate-80 as a solubilizer, but polysorbate-80 is prone to rancidity during high-temperature sterilization and long-term storage, resulting in an increase in impurity content; and polysorbate-80 itself has relatively high Strong hemolytic and allergic, which will increase the incidence of adverse reactions of injections
And the products added with polysorbate-80 as a solubilizer still have problems such as a small amount of precipitation and solution turbidity during long-term storage, which increases the risk of clinical medication

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Example 1 (the dosage of HS15 is 0.3g / 100ml)

[0025] Bupleurum 1000g

[0026] HS15 3g

[0027] Take 1000g of Bupleurum bupleurum, cut it off, soak it in warm water, distill it with steam, collect the initial distillate, and redistill it again, collect about 1000ml of the heavy distillate, add 3g polyethylene glycol lauryl hydroxystearate, stir to make the oil completely Dissolve, then add 9g of sodium chloride, after dissolving, filter, add water for injection to 1000ml, adjust the pH value, measure the absorbance, fine filter, potting, and sterilize to obtain.

Embodiment 1

[0032] Embodiment 1 and comparative example 1 safety contrast

[0033] Safety judgment basis: according to different prescription products of the present invention ( Embodiment 1 and comparative example 1 ) and the difference and degree of immune response produced by different prescription products and the difference and degree of hemolysis in animals to compare their safety.

[0034] Results: Both the immune response and the hemolytic reaction produced in Example 1 were lower than those in Control Example 1.

[0035] Conclusion: The safety of the Bupleurum drug injection preparation of the present invention (using polyethylene glycol lauryl hydroxystearate as a solubilizer) is obviously better than that of the current commercially available Bupleurum drug injection preparation (using polysorbate-80 as a solubilizer). Solubilizers). It can be expected that in the future clinical application, the occurrence of adverse reactions such as allergy and hemolysis caused by polys...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a radix bupleuri injection drug preparation with higher security and a preparation method thereof, the radix bupleuri injection drug preparation is an injection drug mainly prepared by together dissolving a fresh radix bupleuri extract and polyoxyethylene-660-12-hydroxy stearate (solutol-HS15) as a solubilizer into injection water, and the use amount of the used polyoxyethylene-660-12-hydroxy stearate (solutol-HS15) is 0.3g / 100ml. The literature research in the prior art confirms that the security of the polyoxyethylene-660-12-hydroxy stearate (solutol-HS15) used in the preparation is far better than that of polysorbate-80; moreover, safety experiment shows that the security of a radix bupleuri injection liquid using the polyoxyethylene-660-12-hydroxy stearate (solutol-HS15) as the solubilizer is obviously better than that of a radix bupleuri injection liquid using the polysorbate-80 as a solubilizer.

Description

Technical field [0001] The invention involves the field of pharmaceutical preparations, and specifically involves a refreshment of refreshing diol diol -hydroxyl hydroxyl acid ester and its preparation methods. Background technique [0002] Chaihu injection standards are collected by the Ministry of Health (WS3 -B -3297-98, and the 17th volume of Chinese medicine formula preparations).Take Chaihu 1000g, cut off, add water temperature, distille through water vapor, collect the initial distillation, and then distille, collect a distillation of about 1000ml, add 3g of polyshan pear ester-80, stir to fully dissolve the oil, add 9g chlorine chlorine, then add 9g chlorine chlorineAfter the sodium, after dissolving, filtering, adding water to 1000ml, adjusting the pH value, determining absorption, fine filtering, irrigation, sterilization, and obtaining. [0003] Chaihu injection has the effect of clearing heat and solving the table.Clinically for the treatment of fever of colds, popula...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/233A61K47/34A61K9/08A61P11/00A61P31/16A61P33/06A61P29/02
CPCY02A50/30
Inventor 张浩金红娣张熠
Owner CHENGDU LIST PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products